Dr Asima Mukhopadhyay is a clinical scientist and one of India's leading voices in women's cancer research. She is the co-developer of the PARP inhibitor Rucaparib, an anti-cancer drug, and has done groundbreaking research in the field of ovarian cancer.
/english-betterindia/media/post_attachments/uploads/2021/02/30622-m.jpg)